Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Phase 1 Completed
174 enrolled
Proton Radiation for Chordomas and Chondrosarcomas
Phase NA Completed
54 enrolled 11 charts
PRIMHADRON
Completed
62 enrolled
ROOT
Completed
167 enrolled
Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs Resection
Completed
62 enrolled
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
Phase 1 Completed
184 enrolled 20 charts
ImmunoSarc
Phase 1/2 Completed
197 enrolled
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase 2 Completed
78 enrolled 11 charts
Osteosarcoma
Phase 2 Completed
32 enrolled 11 charts
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Phase 2 Completed
Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
Phase 2 Completed
47 enrolled 10 charts
Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
Phase 1/2 Completed
21 enrolled 33 charts
AIAC
Phase NA Completed
40 enrolled
MACIST
Phase 1/2 Completed
15 enrolled
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Phase 1/2 Completed
24 enrolled 14 charts
Trial of Dasatinib in Advanced Sarcomas
Phase 2 Completed
366 enrolled 16 charts
Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors
Phase 2 Completed
20 enrolled 15 charts
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Phase 1/2 Completed
78 enrolled 11 charts
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
Phase 2 Completed
20 enrolled 10 charts
Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use
Phase NA Completed
56 enrolled
A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas
Phase 2 Completed
72 enrolled
CH01
Completed
189 enrolled
Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
Phase 1/2 Completed
381 enrolled
High-dose ICE With Amifostine
Phase 2 Completed
24 enrolled
CONDRO1
Completed
102 enrolled
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
Phase 1 Completed
3 enrolled
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Phase 2 Completed
185 enrolled
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
Phase 1/2 Completed
70 enrolled
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Phase 2 Completed
53 enrolled 6 charts
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Phase 1 Completed
37 enrolled
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
121 enrolled
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Phase 3 Completed
130 enrolled 9 charts
Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
Phase 2 Completed
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Alanosine in Treating Patients With Cancer
Phase 2 Completed
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
Phase 2 Completed
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
Phase 1 Completed
60 enrolled
IPI-926 Extension Protocol for Continuation of Treatment With IPI-926
Phase NA Completed
9 enrolled
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Phase 2 Completed
54 enrolled 8 charts
S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone
Phase 2 Completed
60 enrolled
S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
Phase 2 Completed
75 enrolled
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1 Completed
26 enrolled